Innospec (IOSP) Expected to Post Earnings of $0.98 Per Share

Equities research analysts forecast that Innospec (NASDAQ:IOSP) will post $0.98 earnings per share (EPS) for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for Innospec’s earnings. Innospec posted earnings per share of $1.00 in the same quarter last year, which suggests a negative year over year growth rate of 2%. The company is expected to issue its next earnings results after the market closes on Tuesday, May 8th.

According to Zacks, analysts expect that Innospec will report full-year earnings of $4.30 per share for the current financial year. For the next year, analysts expect that the firm will report earnings of $4.65 per share. Zacks’ earnings per share averages are an average based on a survey of sell-side research firms that follow Innospec.

Innospec (NASDAQ:IOSP) last announced its quarterly earnings data on Tuesday, February 13th. The specialty chemicals company reported $1.47 EPS for the quarter, topping the Zacks’ consensus estimate of $1.13 by $0.34. The firm had revenue of $353.80 million for the quarter. Innospec had a return on equity of 15.57% and a net margin of 4.73%.



IOSP has been the subject of several recent analyst reports. Zacks Investment Research cut Innospec from a “buy” rating to a “hold” rating in a research note on Wednesday, January 10th. ValuEngine raised Innospec from a “hold” rating to a “buy” rating in a research note on Thursday, March 1st. Finally, BidaskClub cut Innospec from a “hold” rating to a “sell” rating in a research note on Friday, December 15th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $70.50.

In other news, VP Philip John Boon sold 3,558 shares of Innospec stock in a transaction on Thursday, March 15th. The stock was sold at an average price of $69.69, for a total value of $247,957.02. Following the completion of the sale, the vice president now directly owns 31,000 shares of the company’s stock, valued at $2,160,390. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Ian Cleminson sold 2,261 shares of Innospec stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $68.55, for a total value of $154,991.55. Following the completion of the sale, the chief financial officer now directly owns 26,685 shares of the company’s stock, valued at $1,829,256.75. The disclosure for this sale can be found here. In the last three months, insiders have sold 12,112 shares of company stock valued at $832,724. 2.02% of the stock is owned by insiders.

Several hedge funds and other institutional investors have recently modified their holdings of the company. C M Bidwell & Associates Ltd. acquired a new position in Innospec during the 4th quarter worth $142,000. Xact Kapitalforvaltning AB acquired a new position in Innospec during the 4th quarter worth $222,000. SG Americas Securities LLC grew its stake in Innospec by 130.5% during the 3rd quarter. SG Americas Securities LLC now owns 3,738 shares of the specialty chemicals company’s stock worth $230,000 after purchasing an additional 2,116 shares in the last quarter. Amalgamated Bank acquired a new position in Innospec during the 4th quarter worth $245,000. Finally, Quadrature Capital Ltd acquired a new position in Innospec during the 4th quarter worth $258,000. 90.83% of the stock is owned by institutional investors and hedge funds.

IOSP stock traded up $0.60 during midday trading on Friday, hitting $70.80. 8,056 shares of the company’s stock were exchanged, compared to its average volume of 116,067. The company has a quick ratio of 1.34, a current ratio of 2.15 and a debt-to-equity ratio of 0.26. The stock has a market cap of $1,730.58, a price-to-earnings ratio of 15.08 and a beta of 1.03. Innospec has a 1-year low of $54.10 and a 1-year high of $74.30.

TRADEMARK VIOLATION NOTICE: This story was first published by Dakota Financial News and is the property of of Dakota Financial News. If you are accessing this story on another publication, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this story can be viewed at https://dakotafinancialnews.com/2018/04/13/innospec-iosp-expected-to-post-earnings-of-0-98-per-share.html.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals for use as fuel additives, ingredients for personal care, home care, agrochemical, mining and other applications, and oilfield chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives.

Get a free copy of the Zacks research report on Innospec (IOSP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply